Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
about
Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD MousePlasma sphingolipids and depressive symptoms in coronary artery disease.Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration
P2860
Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
@en
Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
@nl
type
label
Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
@en
Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
@nl
prefLabel
Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
@en
Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
@nl
P2093
P2860
P356
P1476
Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
@en
P2093
P2860
P304
P356
10.3233/JAD-151158
P50
P577
2016-04-12T00:00:00Z